l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson’s Disease
出版年份 2019 全文链接
标题
l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson’s Disease
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-10-03
DOI
10.3389/fphar.2019.01119
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease
- (2019) Constant V.M. Verschuur et al. NEW ENGLAND JOURNAL OF MEDICINE
- α1b-Adrenergic Receptor Localization and Relationship to the D1-Dopamine Receptor in the Rat Nucleus Accumbens
- (2018) Darlene A. Mitrano et al. NEUROSCIENCE
- Immunoreactivity of a G protein-coupled l-DOPA receptor GPR143, in Lewy bodies
- (2018) Yoshio Goshima et al. NEUROSCIENCE RESEARCH
- Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update
- (2017) Valerie Voon et al. LANCET NEUROLOGY
- An update on the physiological and therapeutic relevance of GPCR oligomers
- (2017) Batoul Farran PHARMACOLOGICAL RESEARCH
- Folding Underlies Bidirectional Role of GPR37/Pael-R in Parkinson Disease
- (2017) Lina Leinartaité et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease
- (2017) Eduardo De Pablo-Fernandez et al. JAMA Neurology
- Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson’s disease (PD): historical overview and future prospects
- (2016) Toshiharu Nagatsu et al. JOURNAL OF NEURAL TRANSMISSION
- l-3,4-Dihydroxyphenylalanine induces ptosis through a GPR143-independent mechanism in mice
- (2016) Suguru Ueda et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Levodopa-Induced Dyskinesia Is Related to Indirect Pathway Medium Spiny Neuron Excitotoxicity: A Hypothesis Based on an Unexpected Finding
- (2016) Svetlana A. Ivanova et al. Parkinsons Disease
- Expression of ocular albinism 1 (OA1), 3, 4- dihydroxy- L-phenylalanine (DOPA) receptor, in both neuronal and non-neuronal organs
- (2015) Nobuhiko Fukuda et al. BRAIN RESEARCH
- L-Dopa Stimulates Cortisol Secretion through Adrenocorticotropic Hormone Release in Short Children
- (2015) Chrisanthi Marakaki et al. Hormone Research in Paediatrics
- Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat
- (2015) Nirmal Bhide et al. JOURNAL OF NEUROCHEMISTRY
- Levodopa alone compared with levodopa-sparing therapy as initial treatment for Parkinson’s disease: a meta-analysis
- (2015) Cheng-long Xie et al. NEUROLOGICAL SCIENCES
- The GPCR heterotetramer: challenging classical pharmacology
- (2015) Sergi Ferré TRENDS IN PHARMACOLOGICAL SCIENCES
- Pharmacological Treatment of Parkinson Disease
- (2014) Barbara S. Connolly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Cardiovascular Actions of DOPA Mediated by the Gene Product of ocular albinism 1
- (2014) Yoshio Goshima et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Localization of ocular albinism-1 gene product GPR143 in the rat central nervous system
- (2014) Daiki Masukawa et al. NEUROSCIENCE RESEARCH
- The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii
- (2013) Y Hiroshima et al. BRITISH JOURNAL OF PHARMACOLOGY
- GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin
- (2013) Rebecca C. Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapies for dopaminergic-induced dyskinesias in parkinson disease
- (2011) Mildred D. Gottwald et al. ANNALS OF NEUROLOGY
- Levodopa Induces Synthesis of Nerve Growth Factor and Growth Hormone in Patients With Parkinson Disease
- (2011) Thomas Müller et al. CLINICAL NEUROPHARMACOLOGY
- Structural insights into human GPCR protein OA1: a computational perspective
- (2011) Anirban Ghosh et al. JOURNAL OF MOLECULAR MODELING
- Milestones in Parkinson's disease therapeutics
- (2011) Olivier Rascol et al. MOVEMENT DISORDERS
- Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease
- (2011) J. Eric Ahlskog PHYSIOLOGY & BEHAVIOR
- Asymmetry of GPCR oligomers supports their functional relevance
- (2011) Pascal Maurice et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Signaling pathways in melanosome biogenesis and pathology
- (2010) Maria Vittoria Schiaffino INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- 1-Adrenoceptors Mediate Dihydroxyphenylalanine-Induced Activity in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaques
- (2008) N. P. Visanji et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Reciprocal Regulation of Dopamine D1 and D3 Receptor Function and Trafficking by Heterodimerization
- (2008) C. Fiorentini et al. MOLECULAR PHARMACOLOGY
- L-DOPA Is an Endogenous Ligand for OA1
- (2008) Vanessa M Lopez et al. PLOS BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now